Click for best price
Protein Degradation Therapy Market Size, Share 2023
Targeted protein degradation (TPD) has surfaced as a novel and innovative chemical tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates complete removal of the protein molecules from within or outside the cell. While the pioneering Proteolysis-Targeting Chimera (PROTAC) technology and molecular glues hijack the ubiquitin-proteasome system, newer modalities co-opt autophagy or the endo-lysosomal pathway.
This report aims to provide a comprehensive presentation of the global market for Protein Degradation Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Degradation Therapy. This report contains market size and forecasts of Protein Degradation Therapy in global, including the following market information:
Global Protein Degradation Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Protein Degradation Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
ARV-110 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Protein Degradation Therapy include Arvinas, Nurix Therapeutics, Kymera Therapeutics and C4 Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Protein Degradation Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Protein Degradation Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Protein Degradation Therapy Market Segment Percentages, by Type, 2022 (%)
ARV-110
ARV-471
Other
Global Protein Degradation Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Protein Degradation Therapy Market Segment Percentages, by Application, 2022 (%)
Cancer
Neuroscience
Other
Global Protein Degradation Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Protein Degradation Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Protein Degradation Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Protein Degradation Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Arvinas
Nurix Therapeutics
Kymera Therapeutics
C4 Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Protein Degradation Therapy, market overview.
Chapter 2: Global Protein Degradation Therapy market size in revenue.
Chapter 3: Detailed analysis of Protein Degradation Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein Degradation Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Protein Degradation Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Protein Degradation Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Protein Degradation Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Protein Degradation Therapy Overall Market Size
2.1 Global Protein Degradation Therapy Market Size: 2022 VS 2030
2.2 Global Protein Degradation Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Protein Degradation Therapy Players in Global Market
3.2 Top Global Protein Degradation Therapy Companies Ranked by Revenue
3.3 Global Protein Degradation Therapy Revenue by Companies
3.4 Top 3 and Top 5 Protein Degradation Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Protein Degradation Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Protein Degradation Therapy Players in Global Market
3.6.1 List of Global Tier 1 Protein Degradation Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Protein Degradation Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Protein Degradation Therapy Market Size Markets, 2022 & 2030
4.1.2 ARV-110
4.1.3 ARV-471
4.1.4 Other
4.2 By Type - Global Protein Degradation Therapy Revenue & Forecasts
4.2.1 By Type - Global Protein Degradation Therapy Revenue, 2018-2023
4.2.2 By Type - Global Protein Degradation Therapy Revenue, 2024-2030
4.2.3 By Type - Global Protein Degradation Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Protein Degradation Therapy Market Size, 2022 & 2030
5.1.2 Cancer
5.1.3 Neuroscience
5.1.4 Other
5.2 By Application - Global Protein Degradation Therapy Revenue & Forecasts
5.2.1 By Application - Global Protein Degradation Therapy Revenue, 2018-2023
5.2.2 By Application - Global Protein Degradation Therapy Revenue, 2024-2030
5.2.3 By Application - Global Protein Degradation Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Protein Degradation Therapy Market Size, 2022 & 2030
6.2 By Region - Global Protein Degradation Therapy Revenue & Forecasts
6.2.1 By Region - Global Protein Degradation Therapy Revenue, 2018-2023
6.2.2 By Region - Global Protein Degradation Therapy Revenue, 2024-2030
6.2.3 By Region - Global Protein Degradation Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Protein Degradation Therapy Revenue, 2018-2030
6.3.2 US Protein Degradation Therapy Market Size, 2018-2030
6.3.3 Canada Protein Degradation Therapy Market Size, 2018-2030
6.3.4 Mexico Protein Degradation Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Protein Degradation Therapy Revenue, 2018-2030
6.4.2 Germany Protein Degradation Therapy Market Size, 2018-2030
6.4.3 France Protein Degradation Therapy Market Size, 2018-2030
6.4.4 U.K. Protein Degradation Therapy Market Size, 2018-2030
6.4.5 Italy Protein Degradation Therapy Market Size, 2018-2030
6.4.6 Russia Protein Degradation Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Protein Degradation Therapy Market Size, 2018-2030
6.4.8 Benelux Protein Degradation Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Protein Degradation Therapy Revenue, 2018-2030
6.5.2 China Protein Degradation Therapy Market Size, 2018-2030
6.5.3 Japan Protein Degradation Therapy Market Size, 2018-2030
6.5.4 South Korea Protein Degradation Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Protein Degradation Therapy Market Size, 2018-2030
6.5.6 India Protein Degradation Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Protein Degradation Therapy Revenue, 2018-2030
6.6.2 Brazil Protein Degradation Therapy Market Size, 2018-2030
6.6.3 Argentina Protein Degradation Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Protein Degradation Therapy Revenue, 2018-2030
6.7.2 Turkey Protein Degradation Therapy Market Size, 2018-2030
6.7.3 Israel Protein Degradation Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Protein Degradation Therapy Market Size, 2018-2030
6.7.5 UAE Protein Degradation Therapy Market Size, 2018-2030
7 Protein Degradation Therapy Companies Profiles
7.1 Arvinas
7.1.1 Arvinas Company Summary
7.1.2 Arvinas Business Overview
7.1.3 Arvinas Protein Degradation Therapy Major Product Offerings
7.1.4 Arvinas Protein Degradation Therapy Revenue in Global Market (2018-2023)
7.1.5 Arvinas Key News & Latest Developments
7.2 Nurix Therapeutics
7.2.1 Nurix Therapeutics Company Summary
7.2.2 Nurix Therapeutics Business Overview
7.2.3 Nurix Therapeutics Protein Degradation Therapy Major Product Offerings
7.2.4 Nurix Therapeutics Protein Degradation Therapy Revenue in Global Market (2018-2023)
7.2.5 Nurix Therapeutics Key News & Latest Developments
7.3 Kymera Therapeutics
7.3.1 Kymera Therapeutics Company Summary
7.3.2 Kymera Therapeutics Business Overview
7.3.3 Kymera Therapeutics Protein Degradation Therapy Major Product Offerings
7.3.4 Kymera Therapeutics Protein Degradation Therapy Revenue in Global Market (2018-2023)
7.3.5 Kymera Therapeutics Key News & Latest Developments
7.4 C4 Therapeutics
7.4.1 C4 Therapeutics Company Summary
7.4.2 C4 Therapeutics Business Overview
7.4.3 C4 Therapeutics Protein Degradation Therapy Major Product Offerings
7.4.4 C4 Therapeutics Protein Degradation Therapy Revenue in Global Market (2018-2023)
7.4.5 C4 Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Protein Degradation Therapy Market Opportunities & Trends in Global Market
Table 2. Protein Degradation Therapy Market Drivers in Global Market
Table 3. Protein Degradation Therapy Market Restraints in Global Market
Table 4. Key Players of Protein Degradation Therapy in Global Market
Table 5. Top Protein Degradation Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Protein Degradation Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Protein Degradation Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Protein Degradation Therapy Product Type
Table 9. List of Global Tier 1 Protein Degradation Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Protein Degradation Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Protein Degradation Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Protein Degradation Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Protein Degradation Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Protein Degradation Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Protein Degradation Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Protein Degradation Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Protein Degradation Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Protein Degradation Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Protein Degradation Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Protein Degradation Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Protein Degradation Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Protein Degradation Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Protein Degradation Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Protein Degradation Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Protein Degradation Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Protein Degradation Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Protein Degradation Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Protein Degradation Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Protein Degradation Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Arvinas Company Summary
Table 31. Arvinas Protein Degradation Therapy Product Offerings
Table 32. Arvinas Protein Degradation Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Arvinas Key News & Latest Developments
Table 34. Nurix Therapeutics Company Summary
Table 35. Nurix Therapeutics Protein Degradation Therapy Product Offerings
Table 36. Nurix Therapeutics Protein Degradation Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Nurix Therapeutics Key News & Latest Developments
Table 38. Kymera Therapeutics Company Summary
Table 39. Kymera Therapeutics Protein Degradation Therapy Product Offerings
Table 40. Kymera Therapeutics Protein Degradation Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Kymera Therapeutics Key News & Latest Developments
Table 42. C4 Therapeutics Company Summary
Table 43. C4 Therapeutics Protein Degradation Therapy Product Offerings
Table 44. C4 Therapeutics Protein Degradation Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. C4 Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Protein Degradation Therapy Segment by Type in 2022
Figure 2. Protein Degradation Therapy Segment by Application in 2022
Figure 3. Global Protein Degradation Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Protein Degradation Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Protein Degradation Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Protein Degradation Therapy Revenue in 2022
Figure 8. By Type - Global Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Protein Degradation Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Protein Degradation Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 16. US Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 28. China Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Protein Degradation Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Protein Degradation Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Arvinas Protein Degradation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Nurix Therapeutics Protein Degradation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Kymera Therapeutics Protein Degradation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. C4 Therapeutics Protein Degradation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
